Manufacturing Cell Therapies: The Paradigm Shift in Health Care of This Century-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Manufacturing Cell Therapies: The Paradigm Shift in Health Care of This Century

Published:2017-06-23 Issue:6 Volume:7 Page:
ISSN:2578-6865
Container-title:NAM Perspectives
language:
Short-container-title:NAM Perspectives

Author:

Haddock Rachel, ,Lin-Gibson Sheng,Lumelsky Nadya,McFarland Richard,Roy Krishnendu,Saha Krishanu,Zhang Jiwen,Zylberberg Claudia, , , , , , ,

Publisher

National Academy of Medicine

Subject

General Medicine

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow-derived mesenchymal stem cells reduce CCl ₄ -induced kidney injury and fibrosis in male Wistar rats;Renal Failure;2024-07-25

2. Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects: Update from 2015 review;Cryobiology;2024-06

3. CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine;Current Gene Therapy;2024-06

4. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off‐the‐shelf versatile tumor delivery vehicle;Medicinal Research Reviews;2024-02

5. Cellular therapies: Hematology and beyond;Seminars in Hematology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP